PROTAC エナビリング・フォーミュレーションイン・ビボ:ポリメリック・キャリアEudragit EPOの影響
Nicole Hofmann1,2, Florian Johann1, Katharina Krollik1
1Global Drug Product Development, Orals Development, the Healthcare Business of Merck KGaA, Frankfurter Straße 250, Darmstadt 64293, Germany.
Molecular pharmaceutics
|August 24, 2025
まとめ
タンパク質分解を標的とするキメラ (PROTAC) のスプレー乾燥分散 (SDD) は,in vivoで不十分な曝露を示した. PROTACの溶解と安定化に影響を及ぼした,胆汁塩とリン酸の性能に依存した.
科学分野:
- 医薬品科学
- 薬物の配達
- 薬理学
背景:
- タンパク質分解標的キメラ (PROTACs) は"薬効性のない"標的に対して新しい治療戦略を提供している.
- PROTACは溶解性と生物利用性が低いことが多く,高度な配方方法が必要である.
- 薬理学研究におけるPROTACsの活性化剤は,まだ十分に研究されていない.
研究 の 目的:
- Eudragit PO (EPO) のモデルPROTAC (MS4078) の無形スプレー乾燥分散 (SDD) のインビヴォの薬理学性能を評価する.
- 生理学的条件下でSDDと溶液の過剰飽和と沈殿の行動を in vitroで調査する.
- PROTAC製剤の性能における胆塩とリン酸の役割を明らかにする.
主な方法:
- MS4078とEPOの無形スプレー乾燥分散 (SDD) の開発
- マウスにおけるSDDと溶液製剤を比較した体内薬動学的研究.
- 胆汁塩とフォスフォリピドの濃度が変化する生理的条件を模倣した媒体を用いた2段階のin vitro降水測定法.
主要な成果:
- SDDと溶液製剤の両方では,予期せぬ低レベルの in vivo 曝露を示した.
- In vitroでは,溶液媒体は溶解性の強化剤として作用した.
- SDDは,胆塩とリンパ脂濃度に依存する複雑な溶解プロファイルを示し,EPO,胆塩,リンパ脂を含む相互作用と相分離を示した.
結論:
- 特にEPOを含むPROTAC製剤のインビトロ性能は,胆汁塩およびリン脂との相互作用によって著しく影響を受けます.
- これらの相互作用は,PROTACの溶解化と安定化に影響を与える相分離につながる可能性があります.
- この発見は,PROTAC製剤と薬動学的研究を設計する際に生理学的脂質と胆塩の濃度を考慮する重要性を強調しています.
さらに関連する動画
関連する概念動画
Drug Delivery: Overview
422
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
422
Factors Influencing Drug Absorption: Pharmaceutical Parameters
192
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
192
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
262
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
262
Carrier-Mediated Transport
545
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
545
Drug Delivery: Enteral Route
715
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
715
Drug Delivery: Parenteral Route
831
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
831


